Drug-induced hepatotoxicity.

[1]  B. Ramakrishna,et al.  Diclofenac-induced hepatitis: case report and literature review. , 2008, Liver.

[2]  H. Conjeevaram,et al.  Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.

[3]  K. Ishak,et al.  Diclofenac‐associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions , 1995, Hepatology.

[4]  R. Williams,et al.  Anti-tuberculous therapy and acute liver failure , 1995, The Lancet.

[5]  K. Byth,et al.  Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease , 1995, Hepatology.

[6]  F. Villamil,et al.  Acute Hepatitis Associated with the Chinese Herbal Product Jin Bu Huan , 1994, Annals of Internal Medicine.

[7]  Smilkstein Mj,et al.  Acetaminophen poisoning and liver function. , 1994 .

[8]  M. Bendall,et al.  Fatal hepatic necrosis associated with trazodone and neuroleptic drugs. , 1994, BMJ.

[9]  T. Shiohara,et al.  Cholestatic hepatitis occurring shortly after etretinate therapy. , 1994, Journal of the American Academy of Dermatology.

[10]  S. King.  Calcium Supplements to Prevent Bone Loss , 1994, Annals of Internal Medicine.

[11]  H. Bonkovsky,et al.  Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: Evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency , 1994, Hepatology.

[12]  Quinton Pg,et al.  Terbutaline hepatitis in pregnancy: report of two cases and literature review. , 1994 .

[13]  D. Vetter,et al.  Hepatic side-effects of antibiotics. , 1994, The Journal of antimicrobial chemotherapy.

[14]  D. Pessayre,et al.  Hepatotoxicity of germander in mice. , 1994, Gastroenterology.

[15]  I. Grimm,et al.  Severe cholestasis associated with ticlopidine. , 1994, The American journal of gastroenterology.

[16]  A. Flahault,et al.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. , 1993, Journal of clinical epidemiology.

[17]  D. Kastenberg,et al.  Cholestatic hepatitis associated with the use of nafcillin. , 1993, The American journal of gastroenterology.

[18]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[19]  B. Strom,et al.  Acute Liver Disease Associated with Erythromycins, Sulfonamides, and Tetracyclines , 1993, Annals of Internal Medicine.

[20]  T. Tsang,et al.  Hepatic dysfunction after repeated isoflurane administration. , 1993, Journal of clinical gastroenterology.

[21]  C. Macilwain.  NIH, PDA seek lessons from hepatitis B drug trial deaths , 1993, Nature.

[22]  M. Bourdi,et al.  Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune Hepatitis , 1993, Annals of the New York Academy of Sciences.

[23]  K. Wiedemann,et al.  Toxic hepatitis by clozapine treatment. , 1993, The American journal of psychiatry.

[24]  D. Wysowski,et al.  Fatal and Nonfatal Hepatotoxicity Associated with Flutamide , 1993, Annals of Internal Medicine.

[25]  F. Guengerich,et al.  Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[26]  M. Hamrell,et al.  Hepatomegaly with severe steatosis in HIV‐seropositive patients , 1993, AIDS.

[27]  G. McDonald,et al.  Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.

[28]  A. Rosman,et al.  Induction of cytochrome P‐4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA , 1993, Hepatology.

[29]  M. Ingelman-Sundberg,et al.  Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. , 1993, Experimental and molecular pathology.

[30]  D. Casciano,et al.  HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. , 1993, Biochemical and biophysical research communications.

[31]  Ichikawa Yoshiyuki,et al.  Effects of interleukin 1α on the activities and gene expressions of the cytochrome p450iid subfamily , 1992 .

[32]  K. Byth,et al.  Hepatotoxicity from paracetamol self‐poisoning in western Sydney: a continuing challenge , 1992, The Medical journal of Australia.

[33]  P. Watkins.  Drug metabolism by cytochromes P450 in the liver and small bowel. , 1992, Gastroenterology clinics of North America.

[34]  S. Dawling,et al.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") , 1992, The Lancet.

[35]  Michael Murray.  P450 Enzymes , 1992, Clinical pharmacokinetics.

[36]  C. Hunt,et al.  Effect of age and gender on the activity of human hepatic CYP3A. , 1992, Biochemical pharmacology.

[37]  D. Larrey,et al.  Hepatitis after Germander (Teucrium chamaedrys) Administration: Another Instance of Herbal Medicine Hepatotoxicity , 1992, Annals of Internal Medicine.

[38]  T. A. Dalton,et al.  Hepatotoxicity associated with sustained-release niacin. , 1992, The American journal of medicine.

[39]  P. Thomas,et al.  Modulation of the levels of cytochromes P450 in rat liver and lung by dietary lipid. , 1992, Biochemical pharmacology.

[40]  S. Imaoka,et al.  Expression of hepatic microsomal cytochrome P450s as altered by uremia. , 1992, Biochemical pharmacology.

[41]  C. Hunt,et al.  Hepatic cytochrome P-4503A (CYP3A) activity in the elderly , 1992, Mechanisms of Ageing and Development.

[42]  C. Ioannides,et al.  Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. , 1992, Biochemical pharmacology.

[43]  P. Korlipara,et al.  Combined nitrofurantoin toxicity to liver and lung. , 1992, Gastroenterology.

[44]  E. Chapnick,et al.  Zidovudine‐induced hepatitis , 1992, Journal of internal medicine.

[45]  D. Larrey,et al.  Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. , 1992, Gut.

[46]  G. Hebbard,et al.  Augmentin‐induced jaundice with a fatal outcome , 1992, The Medical journal of Australia.

[47]  A. Blum.  Ofloxacin-induced acute severe hepatitis. , 1991, Southern medical journal.

[48]  J. Tredger,et al.  Drug metabolism and hepatotoxicity. , 1991, Gut.

[49]  K. K. Lai,et al.  Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). , 1991, Annals of internal medicine.

[50]  C. Shikuma,et al.  Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. , 1991, Journal of the American Academy of Dermatology.

[51]  A. Geubel,et al.  Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. , 1991, Gastroenterology.

[52]  E. Schiff,et al.  Hepatic dysfunction accompanying acute cocaine intoxication. , 1991, Journal of hepatology.

[53]  D. Pessayre,et al.  Fulminant hepatitis after lisinopril administration. , 1990, Gastroenterology.

[54]  L. Pohl.  Drug-Induced Allergic Hepatitis , 1990, Seminars in liver disease.

[55]  N. Benowitz,et al.  Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. , 1990, The New England journal of medicine.

[56]  A. López-Navidad,et al.  Norfloxacin-induced hepatotoxicity. , 1990, Journal of hepatology.

[57]  J. McCutchan,et al.  Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. , 1990, Annals of internal medicine.

[58]  J. Boyer,et al.  Hepatic toxicity of Vitamin A and synthetic retinoids , 1990, Journal of gastroenterology and hepatology.

[59]  R. Planas,et al.  Fatal submassive necrosis of the liver associated with piroxicam. , 1990, The American journal of gastroenterology.

[60]  F. Saibil,et al.  Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. , 1990, Journal of clinical gastroenterology.

[61]  D. Petersen,et al.  Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. , 1990, Alcoholism, clinical and experimental research.

[62]  L. Jeffers,et al.  Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. , 1989, The American journal of gastroenterology.

[63]  P. Hayes,et al.  Hepatotoxicity of herbal remedies. , 1989, BMJ.

[64]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[65]  K. Ishak,et al.  Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients , 1989, Hepatology.

[66]  G. Knapp,et al.  Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) , 1988, The New England journal of medicine.

[67]  M MurieCarrillodeAlbornoz,et al.  [Toxic and drug-induced hepatitis]. , 1988 .

[68]  A. Haspels,et al.  Oral contraceptives and hepatocellular carcinoma , 1986 .

[69]  M. Josephson,et al.  Amiodarone Hepatotoxicity: A Clinicopathologic Study of Five Patients , 1986 .

[70]  L. Seeff,et al.  Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. , 1986, Annals of internal medicine.

[71]  K. Ishak,et al.  Ticrynafen‐Associated Hepatic Injury: Analysis of 340 Cases , 1984, Hepatology.

[72]  J. D. Barker,et al.  Chronic excessive acetaminophen use and liver damage. , 1977, Annals of internal medicine.

[73]  P. Heller,et al.  Letter: Severe hypersensitivity to diphenylhydantoin with circulating antibodies to the drug. , 1975, Annals of internal medicine.

[74]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.

[75]  R. Peters,et al.  Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. , 1971, The New England journal of medicine.

[76]  R. Baerg,et al.  Centrilobular hepatic necrosis and acute renal failure in "solvent sniffers". , 1970, Annals of internal medicine.

[77]  J. Lindenbaum,et al.  HEPATIC NECROSIS ASSOCIATED WITH HALOTHANE ANESTHESIA , 1963, The New England journal of medicine.

[78]  S. Hübscher,et al.  Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. , 1994, Journal of hepatology.

[79]  Y. Horsmans,et al.  Subfulminant hepatitis requiring liver transplantation after benzarone administration. , 1994, Journal of hepatology.

[80]  A. Arieff,et al.  Lactic Acidosis Complicating the Acquired Immunodeficiency Syndrome , 1993, Annals of Internal Medicine.

[81]  U. Christen,et al.  Mechanisms of halothane toxicity: novel insights. , 1993, Pharmacology & therapeutics.

[82]  A. Keegan.  Doxepin-induced recurrent acute hepatitis. , 1993, Australian and New Zealand journal of medicine.

[83]  F. Gonzalez,et al.  Human cytochromes P450: problems and prospects. , 1992, Trends in pharmacological sciences.

[84]  J. Perper,et al.  Hepatotoxicity associated with cocaine abuse. , 1992, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[85]  S. Wrighton,et al.  The human hepatic cytochromes P450 involved in drug metabolism. , 1992, Critical reviews in toxicology.

[86]  F. Guengerich,et al.  Human cytochrome P-450 enzymes. , 1992, Life sciences.

[87]  T. Wolff,et al.  Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes. , 1992, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[88]  P. Gelas,et al.  Hépatite aiguë sévère à la pentamidine au cours du traitement d'une pneumocystose liée au SIDA. , 1991 .

[89]  F. Carnot,et al.  Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments. , 1991, Journal of hepatology.

[90]  V. Guido,et al.  Early hepatitis during intravenous amiodarone administration. , 1991, Cardiology.

[91]  R. Busuttil,et al.  Amanita poisoning: treatment and the role of liver transplantation. , 1989, The American journal of medicine.

[92]  P. Beaune,et al.  Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[93]  M. Black,et al.  Drug induced liver disease. , 1983, Postgraduate medical journal.

[94]  H. Zimmerman,et al.  Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .